Published in Addiction on March 17, 2014
Prevalence of Marijuana Use Disorders in the United States Between 2001-2002 and 2012-2013. JAMA Psychiatry (2015) 2.44
Pharmacotherapies for cannabis dependence. Cochrane Database Syst Rev (2014) 1.03
Keep off the grass? Cannabis, cognition and addiction. Nat Rev Neurosci (2016) 1.01
Are IQ and educational outcomes in teenagers related to their cannabis use? A prospective cohort study. J Psychopharmacol (2016) 0.90
Examining the profile of high-potency cannabis and its association with severity of cannabis dependence. Psychol Med (2015) 0.87
Commentary on van der Pol et al. (2014): Reconsidering the association between cannabis exposure and dependence. Addiction (2014) 0.78
Are adolescents more vulnerable to the harmful effects of cannabis than adults? A placebo-controlled study in human males. Transl Psychiatry (2016) 0.75
Dutch government pressured to reconsider planned re-scheduling of cannabis in drug law. Addiction (2014) 0.75
No smoke, no fire: What the initial literature suggests regarding vapourized cannabis and respiratory risk. Can J Respir Ther (2015) 0.75
Acute memory and psychotomimetic effects of cannabis and tobacco both 'joint' and individually: a placebo-controlled trial. Psychol Med (2017) 0.75
Variation in cannabis potency and prices in a newly-legal market: Evidence from 30 million cannabis sales in Washington State. Addiction (2017) 0.75
Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. JAMA (2004) 22.38
Use of mental health services for anxiety, mood, and substance disorders in 17 countries in the WHO world mental health surveys. Lancet (2007) 8.24
Cross-national prevalence and risk factors for suicidal ideation, plans and attempts. Br J Psychiatry (2008) 5.90
Cross-national epidemiology of DSM-IV major depressive episode. BMC Med (2011) 4.52
Cross-national analysis of the associations among mental disorders and suicidal behavior: findings from the WHO World Mental Health Surveys. PLoS Med (2009) 3.38
Anxiety disorders and risk for suicidal ideation and suicide attempts: a population-based longitudinal study of adults. Arch Gen Psychiatry (2005) 3.33
Duration of major depressive episodes in the general population: results from The Netherlands Mental Health Survey and Incidence Study (NEMESIS). Br J Psychiatry (2002) 3.28
The prevalence of treated and untreated mental disorders in five countries. Health Aff (Millwood) (2003) 3.17
Development of lifetime comorbidity in the World Health Organization world mental health surveys. Arch Gen Psychiatry (2011) 3.01
Mental disorders among persons with chronic back or neck pain: results from the World Mental Health Surveys. Pain (2007) 2.95
Common chronic pain conditions in developed and developing countries: gender and age differences and comorbidity with depression-anxiety disorders. J Pain (2008) 2.58
Costs of nine common mental disorders: implications for curative and preventive psychiatry. J Ment Health Policy Econ (2006) 2.56
Treatment of suicidal people around the world. Br J Psychiatry (2011) 2.34
The prevalence and correlates of binge eating disorder in the World Health Organization World Mental Health Surveys. Biol Psychiatry (2013) 2.31
Neurocognitive functions in pathological gambling: a comparison with alcohol dependence, Tourette syndrome and normal controls. Addiction (2006) 2.23
Extending the treatment options in alcohol dependence: a randomized controlled study of as-needed nalmefene. Biol Psychiatry (2012) 2.10
Drop out from out-patient mental healthcare in the World Health Organization's World Mental Health Survey initiative. Br J Psychiatry (2012) 2.09
Does cannabis use predict the first incidence of mood and anxiety disorders in the adult population? Addiction (2007) 1.95
Incidence and course of suicidal ideation and suicide attempts in the general population. Can J Psychiatry (2009) 1.94
Heroin-assisted treatment as a response to the public health problem of opiate dependence. Eur J Public Health (2002) 1.89
Should there be both categorical and dimensional criteria for the substance use disorders in DSM-V? Addiction (2006) 1.88
Decision making in pathological gambling: a comparison between pathological gamblers, alcohol dependents, persons with Tourette syndrome, and normal controls. Brain Res Cogn Brain Res (2005) 1.88
Lifetime prevalence estimates of major depression: an indirect estimation method and a quantification of recall bias. Eur J Epidemiol (2005) 1.86
Childhood predictors of adult attention-deficit/hyperactivity disorder: results from the World Health Organization World Mental Health Survey Initiative. Biol Psychiatry (2008) 1.82
Perceived barriers to mental health service utilization in the United States, Ontario, and the Netherlands. Psychiatr Serv (2007) 1.82
Reduced-risk drinking as a viable treatment goal in problematic alcohol use and alcohol dependence. J Psychopharmacol (2013) 1.79
Predictors of the 2-year recurrence and persistence of alcohol dependence. Addiction (2012) 1.78
Evaluating the drug use "gateway" theory using cross-national data: consistency and associations of the order of initiation of drug use among participants in the WHO World Mental Health Surveys. Drug Alcohol Depend (2010) 1.78
Cannabis use and expression of mania in the general population. J Affect Disord (2006) 1.76
Modified WHODAS-II provides valid measure of global disability but filter items increased skewness. J Clin Epidemiol (2008) 1.74
Prediction of relapse to frequent heroin use and the role of methadone prescription: an analysis of the Amsterdam Cohort Study among drug users. Drug Alcohol Depend (2005) 1.69
Alcohol use disorders and the course of depressive and anxiety disorders. Br J Psychiatry (2012) 1.66
Why gamblers fail to win: a review of cognitive and neuroimaging findings in pathological gambling. Neurosci Biobehav Rev (2009) 1.66
Cognition in novice ecstasy users with minimal exposure to other drugs: a prospective cohort study. Arch Gen Psychiatry (2007) 1.62
Attentional bias predicts heroin relapse following treatment. Addiction (2006) 1.61
The role of criterion A2 in the DSM-IV diagnosis of posttraumatic stress disorder. Biol Psychiatry (2010) 1.60
Comparison of population health status in six european countries: results of a representative survey using the EQ-5D questionnaire. Med Care (2009) 1.60
Psychopathological mechanisms linking childhood traumatic experiences to risk of psychotic symptoms: analysis of a large, representative population-based sample. Schizophr Bull (2014) 1.59
Effects of modafinil on neural correlates of response inhibition in alcohol-dependent patients. Biol Psychiatry (2012) 1.58
What can the Swiss and Dutch trials tell us about the potential risks associated with heroin prescribing? Drug Alcohol Rev (2003) 1.57
Functioning after a major depressive episode: complete or incomplete recovery? J Affect Disord (2004) 1.57
Response perseveration and ventral prefrontal sensitivity to reward and punishment in male problem gamblers and smokers. Neuropsychopharmacology (2008) 1.56
SSRI treatment of borderline personality disorder: a randomized, placebo-controlled clinical trial for female patients with borderline personality disorder. Am J Psychiatry (2002) 1.54
Suicide risk in placebo-controlled trials of treatment for acute manic episode and prevention of manic-depressive episode. Am J Psychiatry (2005) 1.52
Minor depression: risk profiles, functional disability, health care use and risk of developing major depression. J Affect Disord (2004) 1.52
Modafinil modulates resting-state functional network connectivity and cognitive control in alcohol-dependent patients. Biol Psychiatry (2013) 1.49
The relation between multiple pains and mental disorders: results from the World Mental Health Surveys. Pain (2007) 1.46
Outcome of long-term heroin-assisted treatment offered to chronic, treatment-resistant heroin addicts in the Netherlands. Addiction (2009) 1.46
Are scratchcards addictive? The prevalence of pathological scratchcard gambling among adult scratchcard buyers in the Netherlands. Addiction (2003) 1.46
DSM-IV personality disorders in the WHO World Mental Health Surveys. Br J Psychiatry (2009) 1.46
Main traumatic events in Europe: PTSD in the European study of the epidemiology of mental disorders survey. J Trauma Stress (2008) 1.45
Deep brain stimulation restores frontostriatal network activity in obsessive-compulsive disorder. Nat Neurosci (2013) 1.45
Screening for Posttraumatic Stress Disorder: an evaluation of two self-report scales among crime victims. Psychol Assess (2003) 1.44
Grey matter alterations associated with cannabis use: results of a VBM study in heavy cannabis users and healthy controls. Neuroimage (2011) 1.41
Screening for mood and anxiety disorders with the five-item, the three-item, and the two-item Mental Health Inventory. Psychiatry Res (2009) 1.41
Two-year course of depressive and anxiety disorders: results from the Netherlands Study of Depression and Anxiety (NESDA). J Affect Disord (2011) 1.40
Heroin-assisted treatment (HAT) a decade later: a brief update on science and politics. J Urban Health (2007) 1.40
Childhood adversities as risk factors for onset and persistence of suicidal behaviour. Br J Psychiatry (2010) 1.40
Alcohol use disorders in EU countries and Norway: an overview of the epidemiology. Eur Neuropsychopharmacol (2005) 1.39
Associations of serious mental illness with earnings: results from the WHO World Mental Health surveys. Br J Psychiatry (2010) 1.39
Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: a meta-analysis and meta-regression analysis. Drug Alcohol Depend (2011) 1.36
Instability of the ecstasy market and a new kid on the block: mephedrone. J Psychopharmacol (2010) 1.36
The relationship between impulsive choice and impulsive action: a cross-species translational study. PLoS One (2012) 1.33
Initial validation of two opiate craving questionnaires the obsessive compulsive drug use scale and the desires for drug questionnaire. Addict Behav (2002) 1.33
Brain activation patterns associated with cue reactivity and craving in abstinent problem gamblers, heavy smokers and healthy controls: an fMRI study. Addict Biol (2010) 1.30
Properties of the Hopkins Symptom Checklist-25 (HSCL-25) and the Self-Reporting Questionnaire (SRQ-20) as screening instruments used in primary care in Afghanistan. Soc Psychiatry Psychiatr Epidemiol (2007) 1.29
Cumulative traumas and risk thresholds: 12-month PTSD in the World Mental Health (WMH) surveys. Depress Anxiety (2013) 1.28
A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence. Eur Neuropsychopharmacol (2013) 1.27
The COMT val158met polymorphism and brain morphometry in healthy young adults. Neurosci Lett (2006) 1.25
Chronic physical conditions and their association with first onset of suicidal behavior in the world mental health surveys. Psychosom Med (2010) 1.25
Cost utility analysis of co-prescribed heroin compared with methadone maintenance treatment in heroin addicts in two randomised trials. BMJ (2005) 1.23
Distorted expectancy coding in problem gambling: is the addictive in the anticipation? Biol Psychiatry (2012) 1.23
Striatal dopamine transporter availability associated with polymorphisms in the dopamine transporter gene SLC6A3. J Nucl Med (2008) 1.23
Health status of the advanced elderly in six European countries: results from a representative survey using EQ-5D and SF-12. Health Qual Life Outcomes (2010) 1.22
The contribution of working conditions and social support to the onset of depressive and anxiety disorders among male and female employees. Soc Sci Med (2006) 1.21
Cortisol moderates the relationship between testosterone and aggression in delinquent male adolescents. Biol Psychiatry (2006) 1.21
Pharmacokinetics and pharmacodynamics of high doses of pharmaceutically prepared heroin, by intravenous or by inhalation route in opioid-dependent patients. Basic Clin Pharmacol Toxicol (2006) 1.21
Economic costs of neuroticism: a population-based study. Arch Gen Psychiatry (2010) 1.20
Dialectical Behavior Therapy of borderline patients with and without substance use problems. Implementation and long-term effects. Addict Behav (2002) 1.20
A systematic review of the effectiveness of the community reinforcement approach in alcohol, cocaine and opioid addiction. Drug Alcohol Depend (2004) 1.20
Sustained efficacy of dialectical behaviour therapy for borderline personality disorder. Behav Res Ther (2005) 1.19
Psychiatric disorders in detained male adolescents: a systematic literature review. Can J Psychiatry (2010) 1.16
Longitudinal associations of marital quality and marital dissolution with the incidence of DSM-III-R disorders. J Fam Psychol (2006) 1.16
Comorbid psychopathology in adolescents and young adults treated for substance use disorders: a review. Eur Child Adolesc Psychiatry (2006) 1.16
Perceived need for mental health care and service use among adults in Western Europe: results of the ESEMeD project. Psychiatr Serv (2009) 1.16
Determinants of persistence of major depressive episodes in the general population. Results from the Netherlands Mental Health Survey and Incidence Study (NEMESIS). J Affect Disord (2004) 1.15
Psychophysiological determinants and concomitants of deficient decision making in pathological gamblers. Drug Alcohol Depend (2006) 1.15
Ranking the harm of alcohol, tobacco and illicit drugs for the individual and the population. Eur Addict Res (2010) 1.15
Neurobiological substrates of cue-elicited craving and anhedonia in recently abstinent opioid-dependent males. Drug Alcohol Depend (2008) 1.14
Intrauterine cannabis exposure affects fetal growth trajectories: the Generation R Study. J Am Acad Child Adolesc Psychiatry (2009) 1.14
Phenotypically continuous with clinical psychosis, discontinuous in need for care: evidence for an extended psychosis phenotype. Schizophr Bull (2011) 1.14
Predictors of acamprosate efficacy: results from a pooled analysis of seven European trials including 1485 alcohol-dependent patients. Psychopharmacology (Berl) (2004) 1.13
Measuring craving: an attempt to connect subjective craving with cue reactivity. Alcohol Clin Exp Res (2006) 1.13
The suicidal process; prospective comparison between early and later stages. J Affect Disord (2004) 1.13
Hyperresponsiveness of hypothalamic-pituitary-adrenal axis to combined dexamethasone/corticotropin-releasing hormone challenge in female borderline personality disorder subjects with a history of sustained childhood abuse. Biol Psychiatry (2002) 1.13
Neurophysiological evidence for abnormal cognitive processing of drug cues in heroin dependence. Psychopharmacology (Berl) (2003) 1.11
Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries. Value Health (2011) 1.10
Development of depressed mood predicts onset of psychotic disorder in individuals who report hallucinatory experiences. Br J Clin Psychol (2005) 1.09
Same-sex sexuality and quality of life: findings from the Netherlands Mental Health Survey and Incidence Study. Arch Sex Behav (2003) 1.09